论文部分内容阅读
目的 :观察超声与X线钼靶在乳腺癌患者中的诊断效果。方法 :选取2014年4月~2016年5月医院诊治的乳腺癌患者60例,患者均经手术病理确诊。术前行超声、X线钼靶检测,将2种影像诊断结果与手术病理结果进行比较,分析超声与X线钼靶在乳腺癌患者中的诊断价值。结果 :超声及X线钼靶临床表现存在明显的差异。超声诊断表现排在前三位的分别为:不规则团块、实性低回声及纵横径比>1,分别占86.67%、83.33%及60.00%;X线钼靶表现排在前三位分别为:淋巴结肿大、边缘毛刺征及微钙化,分别占:43.33%、38.34%及33.34%;超声诊断联合X线钼靶诊断检出率为93.34%,显著高于超声诊断的83.34%和X线钼靶诊断的81.67%。结论 :乳腺癌患者术前采用超声诊断和X线钼靶诊断效果理想,但是二者联合能进一步提高临床确诊率,值得推广应用。
Objective: To observe the diagnostic value of ultrasound and mammography in patients with breast cancer. Methods: From April 2014 to May 2016, 60 cases of breast cancer were diagnosed and treated in our hospital. All the patients were confirmed by surgery and pathology. Preoperative ultrasound, mammography X-ray, the two diagnostic imaging results and surgical pathology were compared, the diagnostic value of ultrasound and mammography in breast cancer patients. Results: The clinical manifestations of ultrasound and X-ray mammography were significantly different. Ultrasound diagnosis ranked in the top three were: irregular mass, solid hypoechoic and aspect ratio> 1, accounting for 86.67%, 83.33% and 60.00% respectively; X-ray molybdenum target performance in the top three respectively As follows: lymphadenopathy, marginal burr sign and microcalcifications, accounting for 43.33%, 38.34% and 33.34% respectively; the detection rate of ultrasound diagnosis combined with X-ray mammography was 93.34%, significantly higher than that of ultrasound diagnosis 83.34% and X Line molybdenum target diagnosis of 81.67%. Conclusion: The preoperative diagnosis of breast cancer patients with ultrasound and mammography X-ray is effective, but the combination of the two can further improve the clinical diagnosis rate, which is worth popularizing and applying.